Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Physical and functional performance assessment in pediatric oncology: a systematic review
Regine Söntgerath1, Julia Däggelmann2, Sabine V Kesting3,4
1Department of Pediatric Oncology, Hematology and Hemostaseology, University Hospital Leipzig, Leipzig, Germany.
This review identifies 63 physical performance assessments for pediatric cancer patients and survivors. It highlights gaps in research, particularly for certain cancer types and outcomes, guiding future assessment selection.
Area of Science:
- Pediatric Oncology
- Rehabilitation Medicine
- Exercise Science
Background:
- Pediatric cancer patients experience reduced physical performance from diagnosis through survivorship.
- Existing research lacks systematic guidelines for assessing physical performance and function in this population.
- This gap hinders effective clinical practice and research.
Purpose of the Study:
- To systematically compile and describe assessments of physical performance and function in pediatric cancer patients and survivors.
- To cover a range of assessments including cardiorespiratory fitness, muscle strength, speed, balance, flexibility, functional mobility, gait, and motor performance test batteries.
- To provide a foundation for developing standardized assessment protocols.
Main Methods:
- Conducted a systematic search of PubMed, SPORTDiscus, and Cochrane databases.
- Screened 2619 articles based on the Cochrane Handbook of Systematic Reviews.
- Extracted data on patient characteristics, assessments, validity, reliability, and references from 149 included studies.
Main Results:
- Identified 63 distinct assessments across 149 studies involving 11,639 participants.
- Cardiorespiratory fitness and muscle strength were the most frequently evaluated outcomes, primarily in the off-treatment phase.
- Certain outcomes (e.g., speed) and diagnoses (e.g., neuroblastoma) were significantly underrepresented; leukemia patients were the most studied group.
Conclusions:
- Patient heterogeneity and limited data complicate uniform assessment recommendations.
- The findings support researchers and clinicians in selecting appropriate assessments for specific research questions or clinical needs.
- Highlights the need for research on underrepresented subgroups and outcomes to inform future assessment guidelines.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution

